Checchi Capital Advisers’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Buy
+654
New +$200K 0.01% 546
2024
Q2
– Sell
-519
Closed -$205K – 594
2024
Q1
$205K Buy
+519
New +$192K 0.02% 550
2023
Q3
– Sell
-544
Closed -$208K – 590
2023
Q2
$208K Buy
+544
New +$194K 0.02% 530
2022
Q3
– Sell
-612
Closed -$210K – 594
2022
Q2
$210K Sell
612
-422
-41% -$137K 0.02% 538
2022
Q1
$425K Buy
1,034
+1
+0.1% +$391 0.04% 311
2021
Q4
$484K Buy
1,033
+57
+6% +$24.5K 0.04% 260
2021
Q3
$414K Buy
976
+12
+1% +$5.06K 0.04% 282
2021
Q2
$346K Sell
964
-15
-2% -$4.96K 0.03% 325
2021
Q1
$276K Buy
979
+51
+5% +$14.6K 0.03% 397
2020
Q4
$263K Buy
928
+5
+0.5% +$1.4K 0.03% 381
2020
Q3
$254K Sell
923
-175
-16% -$46.3K 0.03% 345
2020
Q2
$249K Buy
+1,098
New +$216K 0.03% 361
2017
Q2
– Sell
-3,215
Closed -$262K – 408
2017
Q1
$262K Sell
3,215
-12
-0.4% -$1K 0.03% 318
2016
Q4
$274K Buy
3,227
+28
+0.9% +$2.2K 0.04% 290
2016
Q3
$238K Buy
3,199
+292
+10% +$23.2K 0.03% 323
2016
Q2
$221K Buy
2,907
+2,900
+41,429% +$211K 0.03% 316
2016
Q1
$0 Buy
+7
New +$421 ﹤0.01% 1617

Other funds holding WST

Checchi Capital Advisers's WST Position: Q2 2026 in Review

Checchi Capital Advisers opened a new position in West Pharmaceutical (WST) in Q2 2026: 654 shares worth $235K. The stake represents 0.01% of the portfolio and ranks #546 among its holdings. This is a return to the name: Checchi Capital Advisers previously reported a position in WST as recently as Q1 2024.

Checchi Capital Advisers first reported a position in WST in Q1 2016 and has held it in 17 quarters since. The position peaked at $484K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Checchi Capital Advisers held 654 shares of West Pharmaceutical worth $235K as of Q2 2026.
  • West Pharmaceutical was a new Checchi Capital Advisers position in Q2 2026.
  • West Pharmaceutical made up 0.01% of Checchi Capital Advisers's portfolio in Q2 2026, its #546 holding.
  • Checchi Capital Advisers first reported a position in West Pharmaceutical in Q1 2016 and has held it in 17 quarters since.
  • Checchi Capital Advisers's West Pharmaceutical position peaked at $484K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.